NASDAQ: PMN
Promis Neurosciences Inc Stock Ownership - Who owns Promis Neurosciences?

Insider buying vs selling

Have Promis Neurosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Neil CashmanChief Scientific Officer2025-02-1015,000$0.97
$14.60kBuy
Madge K. ShafmasterDirector2024-09-2470,000$1.30
$91.00kBuy
Madge K. ShafmasterDirector2024-09-2370,000$1.28
$89.67kBuy
Madge K. ShafmasterDirector2024-09-2060,000$1.25
$75.06kBuy
Michael S. Gordon10% Owner2024-09-1716,292$1.40
$22.81kBuy
Michael S. Gordon10% Owner2024-09-1676,931$1.22
$94.09kBuy

1 of 1

PMN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PMN insiders and whales buy or sell their stock.

PMN Shareholders

What type of owners hold Promis Neurosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Abg Management Ltd11.69%6,058,738$2.61MInsider
Shaf Qic LLC10.01%5,184,760$2.23MInsider
Jeremy M. Sclar8.31%4,305,600$1.85MInsider
Great Point Partners LLC5.11%2,645,128$1.14MInstitution
Michael S. Gordon4.79%2,483,362$1.07MInsider
19 Promis Title4.70%2,435,029$1.05MInsider
Armistice Capital LLC4.13%2,137,896$919.30kInstitution
Sphera Funds Management Ltd3.67%1,899,297$816.70kInstitution
Ally Bridge Group Ny LLC2.58%1,334,428$573.80kInstitution
Madge K. Shafmaster0.40%208,333$89.58kInsider

1 of 3

PMN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PMN16.36%40.99%Net Buying
GDTC0.39%57.45%
NEUP2.62%97.38%
ICU1.73%47.90%Net BuyingNet Buying
PASG48.59%51.41%Net SellingNet Selling

Promis Neurosciences Stock Ownership FAQ

Who owns Promis Neurosciences?

Promis Neurosciences (NASDAQ: PMN) is owned by 16.36% institutional shareholders, 40.99% Promis Neurosciences insiders, and 42.66% retail investors. Abg Management Ltd is the largest individual Promis Neurosciences shareholder, owning 6.06M shares representing 11.69% of the company. Abg Management Ltd's Promis Neurosciences shares are currently valued at $2.61M.

If you're new to stock investing, here's how to buy Promis Neurosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.